Optimization of a Therapeutic Strategy for p16-Positive Oropharyngeal Squamous Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Optimization of Therapeutic Strategy for p16-Positive Oropharyngeal Squamous Cell Carcinoma: Multi-Institutional Observational Study Based on the National Head and Neck Cancer Registry of Japan
Cancer 2020 Jul 10;[EPub Ahead of Print], Y Saito, R Hayashi, Y Iida, T Mizumachi, T Fujii, F Matsumoto, T Beppu, M Yoshida, H Shinomiya, R Kamiyama, M Kitano, K Yokoshima, Y Fujimoto, T Hama, T Yamashita, K Okami, K Miura, T Fujisawa, D Sano, H Kato, S Minami, M Sugasawa, M Masuda, I Ota, S Iwae, R Kawata, N Monden, T Imai, T Asakage, M Okada, T Yoshikawa, K Tanioka, M Kitayama, M Doi, S Fujii, M Fujii, N Oridate, M Nakamizo, S Yoshimoto, A Homma, KI Nibu, K YaneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.